ICUI News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

IC

Mkt Cap

$4.08B

Volume

161.53K

Next Earnings

November 5th

Loading chart

IC

ICUIICU Medical Inc

ICUI

Pay with—

Available Balance0.00

IC

Mkt Cap

$4.08B

Volume

161.53K

Next Earnings

November 5th

Chart Financials Earnings News About Insider Filings

Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve CannabisThe Medical Products industry faces moderate growth prospects with resilient healthcare demand offset by tariff pressures and manufacturing costs. ICU Medical shows strong momentum in infusion systems with improving earnings, Neogen benefits from commercial execution improvements in food and animal safety, while Trulieve Cannabis expects growth acceleration from new markets like Georgia and Texas despite Florida seasonal softness.Zacks Investment Research · Oct 12, 2026

China Airway Management Market Forecast to 2033 - Airway Management Tubes and Intubation Accessories | Revenue, Volume, Pricing, Company Share, and Growth OpportunitiesResearchAndMarkets.com released a comprehensive market report on China's airway management sector, covering historical data from 2018 and forecasts through 2033. The report segments the market into Airway Management Tubes and Intubation Accessories, providing revenue, volume, and pricing analysis. It includes 2025 company share data and profiles of key competitors to support strategic planning and investment decisions in this growing medical device market.GlobeNewswire Inc. · Oct 9, 2026

ICU Medical CFO Brian Bonnell Sells 9,307 SharesICU Medical CFO Brian Bonnell sold 9,307 shares on August 31, 2026, through a pre-planned Rule 10b5-1 trading plan established in June 2026. The sale, valued at $1.6 million, is not considered a red flag as it was scheduled in advance and Bonnell retains 62,443 shares worth $10.8 million. Analysts remain bullish on the stock with an 88% buy rating and a median price target of $195.The Motley Fool · Sep 17, 2026

Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHAThe global drug reconstitution systems market is expected to grow at a 7.0% CAGR from $5.9 billion in 2026 to $10.8 billion by 2035, driven by expanding biologic and biosimilar pipelines, increasing demand for safer drug delivery systems, and the shift toward home healthcare and self-administered therapies. Cartridges lead the market at 50% revenue share, while prefilled syringes are expected to grow faster. Asia-Pacific is projected to achieve the fastest regional growth.GlobeNewswire Inc. · Sep 7, 2026

ICU Medical's General Counsel Sells — The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells — The Smiths Integration Is still playing out.ICU Medical's General Counsel Ruth Sanzone sold 2,447 shares worth ~$304,000 in an open-market transaction. While the Smiths Medical integration nears completion with manufacturing consolidation largely finished, the company faces headwinds from ~$1 billion in net debt, tariff pressures of $40-50 million annually, and a stock down 16% over the past year. The company's ability to achieve its 43% gross margin target and 2x leverage goal remains unproven after three years.The Motley Fool · Jun 10, 2026

EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within WeeksThe Iran-Israel conflict and potential Strait of Hormuz disruption are creating supply chain pressures on medical supplies through petrochemical derivatives. Key inputs like naphtha and methanol used in pharmaceutical packaging and drug synthesis are experiencing price increases. While hospitals haven't yet felt the impact, analysts expect cost pressures on IV bags, tubing, and other critical consumables to surface within 2-4 weeks as the disruption ripples through supply chains.Benzinga · Mar 25, 2026

Intravenous (IV) Solutions Market Size to Reach USD 29.47 Billion by 2035 Due to the Increasing Prevalence of Chronic Diseases Globally | SNS InsiderThe global IV solutions market is projected to grow from USD 13.35 billion in 2025 to USD 29.47 billion by 2035, with a CAGR of 8.24%. Growth is driven by increasing prevalence of chronic diseases, rising hospital admissions, and growing demand for parenteral nutrition and critical care solutions. The U.S. market alone is expected to reach USD 8.39 billion by 2035. North America leads with 40.70% market share, while Asia-Pacific shows the fastest growth at 9.46% CAGR.GlobeNewswire Inc. · Mar 13, 2026

[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)The global intravenous infusion pump market was valued at USD 6.72 billion in 2025 and is projected to reach USD 14.02 billion by 2035, growing at a CAGR of 7.6%. Growth is driven by increasing chronic diseases, aging populations, technological advancements in smart pumps, and rising demand for precise medication delivery in hospitals and home care settings.GlobeNewswire Inc. · Mar 9, 2026

ICU Medical (ICUI) Q2 EPS Jumps 40%ICU Medical reported Q2 2025 earnings with a significant EPS beat of $2.10, exceeding analyst expectations by 40%. Despite strong profitability, the company faces challenges from regulatory issues, tariffs, and segment performance variability, leading to cautious FY2025 guidance.The Motley Fool · Aug 8, 2025

$3.94 Bn IV Hydration Therapy Markets - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030FThe global IV hydration therapy market is expected to grow from $2.51 billion in 2024 to $3.94 billion by 2030, driven by the increasing incidence of chronic illnesses, rising surgical volumes, and the growing number of intravenous drug approvals. Technological advancements and personalized solutions are also boosting consumer demand for home-based, individualized care.GlobeNewswire Inc. · May 30, 2025

to start trading

IC

ICUIICU Medical Inc

ICUI

Pay with—

Available Balance0.00

Your PositionYou don't own any ICUI yet.

Related Tickers

Earnings